Literature DB >> 28659345

Ablation of Neuropilin 1 in Myeloid Cells Exacerbates High-Fat Diet-Induced Insulin Resistance Through Nlrp3 Inflammasome In Vivo.

Xiaoyan Dai1, Imoh Okon1, Zhaoyu Liu1, Tatiana Bedarida1, Qilong Wang1, Tharmarajan Ramprasath1, Miao Zhang2, Ping Song1, Ming-Hui Zou3.   

Abstract

Neuropilin 1 (Nrp1), a coreceptor for class 3 semaphorins and growth factors, is highly expressed in vascular cells and myeloid cells, including macrophages. Unlike well-characterized proangiogenic functions of endothelial cell Nrp1, the contributions of macrophage Nrp1 within the context of metabolic dysfunction remain to be established. The aim of this study was to determine the contributions of macrophage Nrp1 in high-fat diet (HFD)-instigated insulin resistance in vivo. Insulin sensitivity and Nlrp3 inflammasome activation were monitored in wild-type (WT) and myeloid cell-specific Nrp1 knockout (Nrp1myel-KO) mice fed an HFD (60% kcal) for 16 weeks. HFD-fed mice exhibited insulin resistance with reduced levels of Nrp1 in macrophages compared with chow-fed mice. Further, HFD-fed Nrp1myel-KO mice displayed accentuated insulin resistance, enhanced systemic inflammation, and dramatically increased Nlrp3 inflammasome priming and activation. Importantly, knockout of Nlrp3 ablated HFD-induced insulin resistance and inflammation in Nrp1myel-KO mice, indicating that Nrp1 reduction in macrophages instigates insulin resistance by increasing macrophage Nlrp3 inflammasome activation. Mechanistically, Nrp1 deletion activates the nuclear factor-κB pathway, which in turn accentuates the priming of Nlrp3, promotes Nlrp3-ASC inflammasome assembly, and results in the activation of Nlrp3. We conclude that the HFD-instigated Nrp1 reduction in macrophages exacerbates insulin resistance by promoting Nlrp3 inflammasome priming and activation.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28659345      PMCID: PMC5566301          DOI: 10.2337/db17-0132

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  37 in total

Review 1.  Mechanisms and functions of inflammasomes.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

2.  Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.

Authors:  Andrea Casazza; Damya Laoui; Mathias Wenes; Sabrina Rizzolio; Nicklas Bassani; Marco Mambretti; Sofie Deschoemaeker; Jo A Van Ginderachter; Luca Tamagnone; Massimiliano Mazzone
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

Review 3.  Immunological functions of the neuropilins and plexins as receptors for semaphorins.

Authors:  Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

4.  IKK-beta links inflammation to obesity-induced insulin resistance.

Authors:  Melek C Arkan; Andrea L Hevener; Florian R Greten; Shin Maeda; Zhi-Wei Li; Jeffrey M Long; Anthony Wynshaw-Boris; Giuseppe Poli; Jerrold Olefsky; Michael Karin
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

5.  Osteoprotection by semaphorin 3A.

Authors:  Mikihito Hayashi; Tomoki Nakashima; Masahiko Taniguchi; Tatsuhiko Kodama; Atsushi Kumanogoh; Hiroshi Takayanagi
Journal:  Nature       Date:  2012-05-03       Impact factor: 49.962

6.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

8.  Neuropilin-1: a surface marker of regulatory T cells.

Authors:  Dunja Bruder; Michael Probst-Kepper; Astrid M Westendorf; Robert Geffers; Stefan Beissert; Karin Loser; Harald von Boehmer; Jan Buer; Wiebke Hansen
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression.

Authors:  Jeremy T Miyauchi; Danling Chen; Matthew Choi; Jillian C Nissen; Kenneth R Shroyer; Snezana Djordevic; Ian C Zachary; David Selwood; Stella E Tsirka
Journal:  Oncotarget       Date:  2016-03-01
View more
  10 in total

1.  Myeloid cell neuropilin 1 ameliorates high-fat diet-induced insulin resistance via suppression of Nlrp3 inflammasome.

Authors:  Xiaoyan Dai; Imoh Okon; Ming-Hui Zou
Journal:  Macrophage (Houst)       Date:  2017-09-19

2.  PPARδ agonist prevents endothelial dysfunction via induction of dihydrofolate reductase gene and activation of tetrahydrobiopterin salvage pathway.

Authors:  Zihui Zhang; Xinya Xie; Qinyu Yao; Jia Liu; Ying Tian; Chunmiao Yang; Lei Xiao; Nanping Wang
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

3.  Effects of Weight Loss on Adipose and Muscular Neuropilin 1 mRNA Expression in Obesity: Potential Implication in SARS-CoV-2 Infections?

Authors:  Dominik Soll; Finja Beer; Leonard Spranger; Linna Li; Joachim Spranger; Knut Mai
Journal:  Obes Facts       Date:  2021-12-10       Impact factor: 3.942

Review 4.  Animal models for COVID-19: advances, gaps and perspectives.

Authors:  Changfa Fan; Yong Wu; Xiong Rui; Yuansong Yang; Chen Ling; Susu Liu; Shunan Liu; Youchun Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

5.  Proteomic Investigation of Murine Neuronal α7-Nicotinic Acetylcholine Receptor Interacting Proteins.

Authors:  Matthew J Mulcahy; Joao A Paulo; Edward Hawrot
Journal:  J Proteome Res       Date:  2018-10-04       Impact factor: 4.466

6.  NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.

Authors:  Rebecca Ward; Weiguo Li; Yasir Abdul; LaDonya Jackson; Guangkuo Dong; Sarah Jamil; Jessica Filosa; Susan C Fagan; Adviye Ergul
Journal:  Pharmacol Res       Date:  2019-02-25       Impact factor: 7.658

7.  E-cadherin is regulated by GATA-2 and marks the early commitment of mouse hematopoietic progenitors to the basophil and mast cell fates.

Authors:  Anaïs Wanet; Mahmoud A Bassal; Sweta B Patel; Francisco Marchi; Samanta A Mariani; Nouraiz Ahmed; Haoran Zhang; Marta Borchiellini; Sisi Chen; Junyan Zhang; Annalisa Di Ruscio; Kensuke Miyake; Mindy Tsai; Anuya Paranjape; Shin-Young Park; Hajime Karasuyama; Timm Schroeder; Elaine Dzierzak; Stephen J Galli; Daniel G Tenen; Robert S Welner
Journal:  Sci Immunol       Date:  2021-02-05

8.  Neuropilin-1 Expression on CD4 T Cells Is Atherogenic and Facilitates T Cell Migration to the Aorta in Atherosclerosis.

Authors:  Dalia E Gaddis; Lindsey E Padgett; Runpei Wu; Catherine C Hedrick
Journal:  J Immunol       Date:  2019-11-18       Impact factor: 5.426

9.  Weighted Single-Step GWAS Identified Candidate Genes Associated with Growth Traits in a Duroc Pig Population.

Authors:  Donglin Ruan; Zhanwei Zhuang; Rongrong Ding; Yibin Qiu; Shenping Zhou; Jie Wu; Cineng Xu; Linjun Hong; Sixiu Huang; Enqin Zheng; Gengyuan Cai; Zhenfang Wu; Jie Yang
Journal:  Genes (Basel)       Date:  2021-01-19       Impact factor: 4.096

10.  The pore-forming subunit Kir6.1 of the K-ATP channel negatively regulates the NLRP3 inflammasome to control insulin resistance by interacting with NLRP3.

Authors:  Ren-Hong Du; Ming Lu; Cong Wang; Jian-Hua Ding; Guangyu Wu; Gang Hu
Journal:  Exp Mol Med       Date:  2019-08-06       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.